Thermo Fisher Scientific Inc.
NYSE:TMO
Sector
Location
Market Cap
USD 173.97 B
Share Price
USD 460.72
Avg Daily Volume
2,867,856
Change (1 day)
1.31%
Change (1 year)
-23.22%
Change (YTD)
-11.44%
Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 28, 2025: USD 7.58 B
Thermo Fisher Scientific Inc. Operating Cash Flow is USD 7.58 B for the Trailing 12 Months (TTM) ending June 28, 2025, a -18.93% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 29, 2024 was USD 9.35 B, a 21.51% change year over year.
-
Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending July 01, 2023 was USD 7.69 B, a -15.16% change year over year.
-
Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending July 02, 2022 was USD 9.07 B, a -11.55% change year over year.
-
Thermo Fisher Scientific Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending July 03, 2021 was USD 10.25 B, a 94.46% change year over year.
StockViz
Competitors
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
Boston Scientific Corporation
USD 103.14
BSX
+0.18
0.18%
Becton, Dickinson and Company
USD 193.50
BDX
+5.82
3.10%
Fresenius SE & Co. KGaA
USD 50.92
FRE.DE
+1.60
3.26%
Sartorius Stedim Biotech S.A.
USD 194.24
DIM.PA
-1.25
-0.64%
bioMérieux S.A.
USD 145.17
BIM.PA
-0.75
-0.51%
United Therapeutics Corporation
USD 301.50
UTHR
+2.08
0.69%
Medpace Holdings, Inc.
USD 434.35
MEDP
+5.56
1.30%
Revvity, Inc.
USD 86.84
RVTY
+0.38
0.44%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
Exact Sciences Corporation
USD 40.99
EXAS
-2.17
-5.03%
Sysmex Corporation
USD 13.84
6869.T
-0.03
-0.23%
Bio-Techne Corporation
USD 50.42
TECH
+0.27
0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.65
002294.SZ
-0.03
-0.39%
ALK-Abelló A/S
USD 27.79
ALK-B.CO
-1.06
-3.66%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
Boston Scientific Corporation
USD 103.14
BSX
+0.18
0.18%
Becton, Dickinson and Company
USD 193.50
BDX
+5.82
3.10%
Fresenius SE & Co. KGaA
USD 50.92
FRE.DE
+1.60
3.26%
Sartorius Stedim Biotech S.A.
USD 194.24
DIM.PA
-1.25
-0.64%
bioMérieux S.A.
USD 145.17
BIM.PA
-0.75
-0.51%
United Therapeutics Corporation
USD 301.50
UTHR
+2.08
0.69%
Medpace Holdings, Inc.
USD 434.35
MEDP
+5.56
1.30%
Revvity, Inc.
USD 86.84
RVTY
+0.38
0.44%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
Exact Sciences Corporation
USD 40.99
EXAS
-2.17
-5.03%
Sysmex Corporation
USD 13.84
6869.T
-0.03
-0.23%
Bio-Techne Corporation
USD 50.42
TECH
+0.27
0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.65
002294.SZ
-0.03
-0.39%
ALK-Abelló A/S
USD 27.79
ALK-B.CO
-1.06
-3.66%